Atlas Trials

Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases

Clinical trial NCT06480630 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06480630
Sponsor
Anhui Provincial Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Graft Versus Host DiseaseMalignant Hematologic Neoplasm
Start date
2024-07-01
Primary completion
2026-06-30
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.